Home/Filings/4/0000945769-12-000056
4//SEC Filing

April Gary M 4

Accession 0000945769-12-000056

CIK 0000887497other

Filed

Dec 11, 7:00 PM ET

Accepted

Dec 12, 5:07 PM ET

Size

17.0 KB

Accession

0000945769-12-000056

Insider Transaction Report

Form 4
Period: 2012-12-10
April Gary M
President, HCP Division
Transactions
  • Exercise/Conversion

    Common Stock

    2012-12-10$19.59/sh+1,875$36,7313,750 total
  • Sale

    Common Stock

    2012-12-10$35.44/sh5,626$199,3850 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2012-12-101,8751,875 total
    Exercise: $19.59From: 2010-11-12Exp: 2019-11-12Common Stock (1,875 underlying)
  • Exercise/Conversion

    Common Stock

    2012-12-10$5.83/sh+1,875$10,9311,875 total
  • Exercise/Conversion

    Common Stock

    2012-12-10$22.25/sh+1,876$41,7415,626 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2012-12-101,8750 total
    Exercise: $5.83From: 2009-11-13Exp: 2018-11-13Common Stock (1,875 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2012-12-101,8763,750 total
    Exercise: $22.25From: 2011-11-10Exp: 2020-11-10Common Stock (1,876 underlying)
Footnotes (5)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.21 to $35.71, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote [1] of this Form 4.
  • [F2]Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s Amended and Restated Stock Option Plan, which is a 16b-3 Plan.
  • [F3]Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s 2009 Stock Option Plan, which is a 16b-3 Plan.
  • [F4]The option became or becomes exercisable in four (4) equal annual installments beginning on the first anniversary of the grant date.
  • [F5]Other than the options to acquire 5,625shares reflected on this form as still held by Mr. April following the reported transactions, Mr. April is also the holder of additional options to acquire 25,000 shares of Hi-Tech common stock (for total options to acquire 30,625 shares still held by Mr. April), which options were granted on various dates, with various exercise prices, exercise dates, and expiration dates.

Issuer

HI TECH PHARMACAL CO INC

CIK 0000887497

Entity typeother

Related Parties

1
  • filerCIK 0001463267

Filing Metadata

Form type
4
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 5:07 PM ET
Size
17.0 KB